CD19-targetd CAR-T
PBC068
Phase 1 mab active
Quick answer
CD19-targetd CAR-T for Juvenile Dermatomyositis is a Phase 1 program (mab) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PRECISION BIOSCIENCES INC
- Indication
- Juvenile Dermatomyositis
- Phase
- Phase 1
- Modality
- mab
- Status
- active